BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 1360549)

  • 1. [The assessment of clinical usefulness of 131I-MIBG scintigraphy for localization of tumors of sympathetic and adrenomedullary origin--a report of multicenter phase III clinical trials].
    Sasaki Y; Kubo A; Kusakabe K; Masaki H; Endo K; Yamashita M; Nakajo M; Kaneko M
    Kaku Igaku; 1992 Sep; 29(9):1083-98. PubMed ID: 1360549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of clinical utility of 123I-MIBG scintigraphy in localization of tumors of sympathetic and adrenomedullary origin--a report of multicenter phase III clinical trials].
    Ishii K; Kubo A; Kusakabe K; Murata H; Masaki H; Horiike S; Hayashi A; Hara Y
    Kaku Igaku; 2000 Jan; 37(1):43-59. PubMed ID: 10714067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of metastatic medullary thyroid cancer with 131I-MIBG scans in Sipple's syndrome.
    Itoh H; Sugie K; Toyooka S; Kawase M; Mukaino S; Hazama F; Endo K; Torizuka K; Nakao K; Imura H
    Eur J Nucl Med; 1986; 11(12):502-4. PubMed ID: 2874028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical applications of 131I-meta iodobenzylguanidine (131I-MIBG) scintigraphy in Japan].
    Izumi M; Kakezono F; Nagayama Y; Kiriyama T; Yokoyama N; Yamashita S; Morita S; Hirayu H; Kubo I; Ohtakara S
    Kaku Igaku; 1986 Feb; 23(2):145-52. PubMed ID: 2872353
    [No Abstract]   [Full Text] [Related]  

  • 5. [Detection of neural crest tumors by 123I-MIBG scintigraphy].
    Ikekubo K; Hino M; Ootsuka H; Ito H; Yamaguchi H; Dan Y; Masui Y; Bito S; Ohta K; Saiki Y
    Kaku Igaku; 1994 Nov; 31(11):1357-64. PubMed ID: 7837704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sipple's syndrome with liver tumors examined by iodine-131 MIBG and technetium-99m(V)-DMSA.
    Ohta H; Endo K; Fujita T; Koizumi M; Konishi J; Maki A; Mori K; Ozawa K; Inoue G; Nakano Y
    J Nucl Med; 1988 Jun; 29(6):1130-5. PubMed ID: 2897436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pentavalent technetium-99m (V)-DMSA uptake in a pheochromocytoma in a patient with Sipple's syndrome.
    Adams BK; Fataar A; Byrne MJ; Levitt NS; Matley PJ
    J Nucl Med; 1990 Jan; 31(1):106-8. PubMed ID: 1967305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple endocrine neoplasia type 2 with malignant pheochromocytoma--long term follow-up of a case by 131I-meta-iodobenzylguanidine scintigraphy.
    Namba H; Kondo H; Yamashita S; Kimura H; Yokoyama N; Tsuruta M; Sato A; Izumi M; Kinoshita H; Hakariya S
    Ann Nucl Med; 1992 May; 6(2):111-5. PubMed ID: 1352456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iodine-131 metaiodobenzylguanidine for the locating of suspected pheochromocytoma: experience in 400 cases.
    Shapiro B; Copp JE; Sisson JC; Eyre PL; Wallis J; Beierwaltes WH
    J Nucl Med; 1985 Jun; 26(6):576-85. PubMed ID: 2860214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pitfall of Sipple's syndrome diagnosis by 131I-metaiodobenzylguanidine (MIBG).
    Talbot JN; Coutris G; Moulonguet M; Hoang C; Perniceni T; Milhaud G
    J Nucl Med Allied Sci; 1987; 31(4):337-40. PubMed ID: 2895168
    [No Abstract]   [Full Text] [Related]  

  • 11. Imaging of medullary thyroid carcinoma and hyperfunctioning adrenal medulla using iodine-131 metaiodobenzylguanidine.
    Ansari AN; Siegel ME; DeQuattro V; Gazarian LH
    J Nucl Med; 1986 Dec; 27(12):1858-60. PubMed ID: 2878066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnosis of pheochromocytoma by 131I-MIBG scintigraphy].
    Miyanaga N; Hattori K; Shiraiwa H; Hinotsu S; Nemoto R; Koiso K; Takeda T; Ishikawa N
    Hinyokika Kiyo; 1990 Feb; 36(2):105-8. PubMed ID: 2343801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-[131I]iodobenzylguanidine in the scintigraphic evaluation of neural crest tumors.
    Zagar I; Han R; Mitrovic S
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):13-6. PubMed ID: 9002742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iodine-131 MIBG scintigraphy of the extremities in metastatic pheochromocytoma and neuroblastoma.
    Shulkin BL; Shen SW; Sisson JC; Shapiro B
    J Nucl Med; 1987 Mar; 28(3):315-8. PubMed ID: 3102702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyroid uptake of MIBG in Sipple's syndrome.
    Perdrisot R; Rohmer V; Lejeune JJ; Bigorgne JC; Jallet P
    Eur J Nucl Med; 1988; 14(1):37-8. PubMed ID: 2898364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current concepts on the diagnostic use of MIBG in children.
    Shulkin BL; Shapiro B
    J Nucl Med; 1998 Apr; 39(4):679-88. PubMed ID: 9544682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging and uptake mechanism of 131I-meta-iodobenzylguanidine in medullary thyroid carcinoma.
    Oishi S; Sasaki M; Sato T; Hirota Y; Takahashi M
    Endocrinol Jpn; 1986 Jun; 33(3):309-15. PubMed ID: 2875869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 131I-MIBG scintigraphy in neural crest tumours.
    Samuel AM; Murugesan S; Kurkure PA; Advani SH; Sonawane GA; Noronha OP
    Indian J Cancer; 1994 Jun; 31(2):103-10. PubMed ID: 7927441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limitations of 131I-MIBG scintigraphy in locating pheochromocytomas.
    Gough IR; Thompson NW; Shapiro B; Sisson JC
    Surgery; 1985 Jul; 98(1):115-20. PubMed ID: 2861667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pheochromocytoma: diagnosis by scintigraphy using iodine 131 metaiodobenzylguanidine.
    Campeau RJ; Garcia OM; Correa OA; Rege AB
    South Med J; 1991 Oct; 84(10):1221-30. PubMed ID: 1925724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.